SlideShare a Scribd company logo
Population Screening Program and Prenatal
Bio-Oxford

Bio-Oxford is a Brazilian company operating in the in vitro diagnostics market for over
10 years as an authorized distributor for Bio-Rad Laboratories, Inc., a multinational
organization headquartered in the US, market and technology leader in various
segments.
Bio-Oxford has over 1,500 clients throughout Brazil and sells 5.8 million tests for in
vitro diagnosis annually.
Bio-Oxford also develops, imports, and commercializes products and equipment for in
vitro diagnosis of infectious diseases for population screening and prenatal and
neonatal screening.
Bio-Oxford



Bio-Oxford has expertise and works in all segments of the in vitro diagnostics market with a focus and leadership
position in:

POPULATION AND PRENATAL SCREEENING
Equipment, chemical and biological reagents, sample collection kits, logistical and scientific training for infectious
disease screening (AIDS, syphilis, hepatitis B and C, HTLV 1+ 2, toxoplasmosis, rubella, cytomegalovirus) for
population and prenatal screening programs.
a
NEONATAL SCREENING
Equipment, chemical and biological reagents, logistical and scientific training for beta-thalassemia,
hemoglobinopathies, immunological and enzymatic disorders and infectious diseases screening in newborns.
A
Solutions
        Q-Preven
              ● Tests for General Population Screening
              ● Tests for Prenatal Screening
              ● Tests for Newborn Screening




 Blood samples collected on filter paper S&S903
Business Philosophy

● Concept: Large population screening;

● Objective: 100% of the population;

● Method: Dried blood samples collected on filter paper
   (ELISA)


 Aim:
 Expedite access to patients
 Identify epidemiological profile
Procedures for collecting blood on filter paper




                                      See sample enclosed
Advantages

Access   Practicality   Prevention   Innovation   Economy
Advantages
   Access               Practicality    Prevention   Innovation   Economy




• Epidemic moves to the interior

•Need for laboratory
 infrastructure in remote areas

• Filter paper carries the laboratory
structure of urban centers
to regions of difficult access.
Advantages
Access   Practicality         Prevention           Innovation   Economy




         • Easy method for sample collection
            -Whole blood
         •Optimum solid support for antibodies
         •Low volume and little invasive
         •(50ul/spot)
            •Transportation (non-infectious)
            • Simple storage at room temperature
            • Optimum stability
Advantages
Access   Practicality   Prevention           Innovation            Economy




                        •Facilitates diagnosis and, as a result:

                        • Immediate treatment and reduction of
                         serious cases
                        • Increased opportunities for prevention
                        • Reduction of costs of service
Advantages
Access   Practicality      Prevention          Innovation   Economy




                  • This method can be integrated into:

                  •The rural indigenous population

                  •The Family Health Program
Advantages
Access   Practicality   Prevention        Innovation           Economy




                          • Cost reduction
                                  Transport
                                  Storage
                                  Equipment

                                 Material
                                 - Syringe needle
                                 -Collection tubes
                                 - Power (no centrifugation)
The Advantages of Filter Paper vs. the Serum Method
            Logistics                                   Serum                                     Filter paper

           Extraction                                   Syringe                                        Lancet

          Preparation                                Centrifuge                                            -

                                           Controlled temperature
        Conservation                                                                                   Room
                                                    (Ice)
                                                     Styrofoam
            Transport                                                                                Envelope
                                                        (Ice)

           Personnel                                 Specialized                              Simple treatment


Government studies show that, in Brazil, every AIDS patient costs US$4.500 per year, just for drugs. “Interview with Dr. Paulo Roberto
Teixeira, Coordinator of the National STD/AIDS Department, Ministry of Health. Dr. Teixeira is a public health doctor and dermatologist
and follows the AIDS issue from its inception.” Source: Boa Saúde UOL.
Summary

1.   Dried blood samples on filter paper are easy to collect, transport and store.


2.   Results equivalent to those from the alternative testing method in serum.


3.   An excellent solution for areas with no structure or with precarious laboratory
     structure.


4.   Studies by Brazilian institutions show that, contrary to the syringe collection
     method, dried blood samples on filter paper maintain their properties under
     extreme temperature conditions such as 51oC, even when combined with high
     humidity.
Summary




In the Ministry’s assessment, of the 630,000 persons infected in Brazil, 255,000
who carry the virus have still not taken the test
•   SECRETARIA DE VIGILÂNCIA EM SAÚDE
•   Normative instruction SVS/MS No. 151, October 14, 2009
•   Official Gazette October 16, 2009
•   LIST OF REASONS
•   ...“Brazil is going to update the standards for performing anti-HIV tests. The purpose is to
    include the most modern methods to increase the options for performing the exams at
    laboratories from the public and private systems in Brazil.”
•   The main change proposed by the STD/AIDS Department is meant to make testing to
    diagnosis HIV in the laboratory quicker.
•   The new document could also open the way for the first time for doing tests with dried blood,
    using the filter paper collection. The main advantage of the method is the ability to store
    blood samples for up to 12 weeks without refrigeration. This methodology, due to its
    easiness, doesn’t need specialized collection and transport, and, consequently, lowers the
    cost of exams. Another advantage is that the method allows for sending material by mail,
    taking the diagnostic method from the urban centers to more distant locations where there is
    no available laboratory capacity. Technically, the dried blood samples are not considered
    biologically infectious, which facilitates handling and transportation.
The Importance of Prevention


              “HIV infection in the pediatric population is
              a growing problem, mainly in developing
              countries hit by the AIDS epidemic.
              The most frequent means for children to
              become HIV-positive is through their
              mothers, during pregnancy, labor or
              breastfeeding.
The Importance of Prevention
        In the 21st century, the perinatal HIV epidemic
        remains out of control in many countries of the
        world. The Joint Program of the United Nations for
        HIV/AIDS (UNAIDS) estimates that 40 million people
        are living with HIV/AIDS, 5 million people are
        infected every year, of whom nearly 3 million are
        children; of these, 500,000 die as a result of infection
        and 700,000 will acquire new infections in that year,
        and many of them will be dead before reaching
        adolescence.
The Importance of Prevention

 Whatever the disease, it is always better to identify it in the pre-
 symptomatic phase or in its early stages. This is the reason why
 programs that aim at prevention and early diagnosis of various
 pathologies are the main objective of current health initiatives. The
 main purpose of these educational and prevention initiatives is to
 provide all subsidies to publicize the information necessary to
 reduce the rates of infection and mortality.
 For example, treatment of syphilis, a disease that can cause
 blindness or even death in newborns, can be done with a single dose
 of benzathine penicillin in primary cases, or up to three doses (one
 per week), in cases of latent or secondary syphilis.
The Importance of Prevention


   These initiatives can be applied to:
   • General Screening Programs: For men and women, for
   screening of diseases such as AIDS, syphilis, Chagas disease
   and hepatitis B and C.
   • Prenatal Screening Programs: To detect infectious disease
   in women before or during pregnancy.
   • Newborn Screening Programs: Screening (heel prick test)
   in newborns.
The Importance of Prevention
  The importance of diagnostic tests to detect infectious diseases has
  been widely publicized by the Brazilian government, and various
  prevention programs have become mandatory in Brazil, such as the
  newborn screening program which is performed on all children born
  in the country.
  Programs with this scope, given their magnitude, can only be
  implemented using filter paper to collect samples.
  These programs, as well as the use of filter paper, were the subjects
  of reports, such as the two annexed to this presentation, which were
  broadcast on the Brazilian TV news program with the largest
  audience, with a statement by the Brazilian Minister of Health.
AIDS in Brazil

From 1980 to June 2009*, 544,846 AIDS cases were registered in Brazil. During this period,
there were 217,091 deaths due to this disease. Every year, 33,000 to 35,000 new cases of
AIDS are reported. In relation to HIV, the estimate is that there are 630,000 infected
people in the Brazil.

The epidemic grew inland. From 1997 to 2007, the incidence in cities with fewer than
50,000 inhabitants doubled, showing that the epidemic has moved inland. In 1997, the
rate in cities with under 50,000 inhabitants was about eight times less than that reported
for cities with over 500,000 people. In 2007, this ratio dropped to three times.




                                                     Excerpted from:
                                                     Boletim Epidemiológico Aids/DST 2009
                                                     Ministério da Saúde
Syphilis
Around 1 million new cases of syphilis are reported every year in Brazil, according to estimates from
the Ministry of Health. After AIDS, the sexually transmitted disease of most concern to doctors is
syphilis, mainly due to the transmission from mother to child.

From 1998 to June of 2009, 55,124 cases of congenital syphilis (transmitted from mother to child)
were reported in those younger than one year of age in Brazil. On average, 5,000 cases are reported
every year. The Ministry of Health estimates, however, that there should be 12,000 reports annually.

Beginning in 2005, cases of syphilis in pregnant women also began to be reported. From the beginning
of notification up to 2008, 19,608 cases of pregnant women with syphilis were reported, with 6,955
just in the last year – the estimate is that around 48,000 pregnant women contract syphilis annually.

From the perspective of public health, the main challenge in fighting syphilis is the vertical
transmission. During pregnancy, the disease can cause miscarriage and death of the fetus. Its
congenital manifestations include deformed bones, deafness, blindness and neurological problems,
among others, for children.


                                                           Excerpted from:
                                                           Boletim Epidemiológico Aids/DST 2009
                                                           Ministério da Saúde
The chances of vertical transmission of congenital syphilis can
be eliminated and HIV infection can drop to 1%, if adequate
prevention and treatment measures are adopted.




                                     Excerpted from:
                                     Boletim Epidemiológico Aids/DST 2009
                                     Ministério da Saúde
Population Screening Program for Infectious Diseases

What Bio-Oxford provides:

1- Know-How:
Bio-Oxford has been operating in the
Brazilian market for over ten years, and has
experience and extensive knowledge on
the implementation, management and
control of population screening programs
destined to detecting infectious diseases
and disorders in newborns.
Population Screening Program for Infectious Diseases
What Bio-Oxford provides:

2- Automated and/or semi-automated equipment:
High technology equipment for processing of results, duly certified by the major public
health agencies in the world, such as the FDA and the EC.
All the equipment will be transferred under a loan scheme, with no additional cost to
the program.




3- Specialized technical assistance for equipment
maintenance and repair.
Population Screening Program for Infectious Diseases
What Bio-Oxford provides:

4- Collection kit:
All the material needed to collect samples of
blood (model enclosed).

5- Operational Training for Sample Collection:
Training of the process multipliers in the use and care of the materials provided for the
collection, storage, handling and transport of the samples.
Population Screening Program for Infectious Diseases
What Bio-Oxford provides:

6 – Chemical and Biological Reagents: Reagents needed to process samples, tested and
approved by international public health agencies.

7 - Scientific Training: training laboratory personnel in
methods, equipment and accessory operation, and
interpretation of the results of processing the blood
samples collected.
Population Screening Program for Infectious Diseases
What Bio-Oxford provides:

8- Web-based Management Program:
Program for remote access to results based in the web, with access protected by
individual password. (model enclosed).

Ex: www.centrodegenomas.com.br

Login: l (small “L”) 970

Password: bio970
Population Screening Program for Infectious Diseases


                  Bio-Oxford also has scientific knowledge, equipment
                  and reagents to carry out several other programs and
                  tests, such as:


                  A – Prenatal tests to detect:
                           AIDS,
                           Syphilis,
                           Hepatitis B and C,
                           HTLV 1 +2,
                           Toxoplasmosis,
                           Rubella,
                           Cytomegalovirus (CMV)
Newborn screening


                                         B – Tests for Newborns to identify disorders:




                      Tests                                        Disease
Total Thyroxin (T4)                             Congenital hypothyroidism
Thyroid-stimulating hormone (TSH)               Congenital hypothyroidism
PKU enzyme test                                 Phenylketonuria
17-α-Hydroxyprogesterone (17-OHP)               Congenital Adrenal Hyperplasia
Enzymatic galactose test                        Galactosemia
Immunoreactive Trypsin (IRT)                    Cystic fibrosis
Screening for hemoglobin disorders and          Hemoglobin disorders and thalassemia
thalassemia

More Related Content

Similar to Bio Oxford

Apresentação Prime - INGLÊS - programa de triagem (10) ALTERAÇÕES1.ppt (1.103)
Apresentação Prime - INGLÊS - programa de triagem   (10) ALTERAÇÕES1.ppt (1.103)Apresentação Prime - INGLÊS - programa de triagem   (10) ALTERAÇÕES1.ppt (1.103)
Apresentação Prime - INGLÊS - programa de triagem (10) ALTERAÇÕES1.ppt (1.103)Terra Vivos
 
Prime diagnostics
Prime diagnosticsPrime diagnostics
Prime diagnostics
Terra Vivos
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_Manolio
EuroBioForum
 
Lecture 10 : Animal Diseases
Lecture 10 : Animal DiseasesLecture 10 : Animal Diseases
Lecture 10 : Animal Diseases
WiseAcademy
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
ipposi
 
PROJECT CAH NEWBORN SCREENING DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
PROJECT CAH NEWBORN SCREENING  DBS SPECIMEN COLLECTION AND HANDLING dr saras ...PROJECT CAH NEWBORN SCREENING  DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
PROJECT CAH NEWBORN SCREENING DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
RahimiRamli9
 
Dual function camera webinar presentation for webpage
Dual function camera webinar presentation for webpageDual function camera webinar presentation for webpage
Dual function camera webinar presentation for webpage
kphodel
 
Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...
ILRI
 
Vitiligo biobank presentation dec 2012 yv ik
Vitiligo biobank presentation dec 2012 yv ikVitiligo biobank presentation dec 2012 yv ik
Vitiligo biobank presentation dec 2012 yv ik
VR Foundation
 
NIHR partnering with industry
NIHR partnering with industryNIHR partnering with industry
NIHR partnering with industry
Health and Care Innovation Expo
 
The power of information: Achieving a national infection management system
The power of information: Achieving a national infection management systemThe power of information: Achieving a national infection management system
The power of information: Achieving a national infection management system
Health Informatics New Zealand
 
Automationinmicrobiology 100416000026-phpapp01
Automationinmicrobiology 100416000026-phpapp01Automationinmicrobiology 100416000026-phpapp01
Automationinmicrobiology 100416000026-phpapp01shamsudin DrGez
 
Liquid based cytology ( l b c)
Liquid  based  cytology ( l b c)Liquid  based  cytology ( l b c)
Liquid based cytology ( l b c)
vikramsaraswat
 
Earli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohnEarli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohn
Allison Littlejohn
 
Earli19
Earli19Earli19
ILRI’s key programs to address infectious diseases, areas requiring internati...
ILRI’s key programs to address infectious diseases, areas requiring internati...ILRI’s key programs to address infectious diseases, areas requiring internati...
ILRI’s key programs to address infectious diseases, areas requiring internati...
ILRI
 
Covid19: Essentials for the Pharmacy Technician
Covid19: Essentials for the Pharmacy TechnicianCovid19: Essentials for the Pharmacy Technician
Covid19: Essentials for the Pharmacy Technician
National Pharmacy Technician Association
 
BIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASESBIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASES
Dr. Prathamesh Fulsundar
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
Workgroup of European Cancer Patient Advocacy Networks
 

Similar to Bio Oxford (20)

Apresentação Prime - INGLÊS - programa de triagem (10) ALTERAÇÕES1.ppt (1.103)
Apresentação Prime - INGLÊS - programa de triagem   (10) ALTERAÇÕES1.ppt (1.103)Apresentação Prime - INGLÊS - programa de triagem   (10) ALTERAÇÕES1.ppt (1.103)
Apresentação Prime - INGLÊS - programa de triagem (10) ALTERAÇÕES1.ppt (1.103)
 
Julie Corfield
Julie CorfieldJulie Corfield
Julie Corfield
 
Prime diagnostics
Prime diagnosticsPrime diagnostics
Prime diagnostics
 
EuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_ManolioEuroBioForum2014_speaker_Manolio
EuroBioForum2014_speaker_Manolio
 
Lecture 10 : Animal Diseases
Lecture 10 : Animal DiseasesLecture 10 : Animal Diseases
Lecture 10 : Animal Diseases
 
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
Patients Driving Health Innovation - Dr Abaigeal Jackson CF Registry - Octobe...
 
PROJECT CAH NEWBORN SCREENING DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
PROJECT CAH NEWBORN SCREENING  DBS SPECIMEN COLLECTION AND HANDLING dr saras ...PROJECT CAH NEWBORN SCREENING  DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
PROJECT CAH NEWBORN SCREENING DBS SPECIMEN COLLECTION AND HANDLING dr saras ...
 
Dual function camera webinar presentation for webpage
Dual function camera webinar presentation for webpageDual function camera webinar presentation for webpage
Dual function camera webinar presentation for webpage
 
Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...Development of platform techniques to produce cheap, eco-friendly and easy-to...
Development of platform techniques to produce cheap, eco-friendly and easy-to...
 
Vitiligo biobank presentation dec 2012 yv ik
Vitiligo biobank presentation dec 2012 yv ikVitiligo biobank presentation dec 2012 yv ik
Vitiligo biobank presentation dec 2012 yv ik
 
NIHR partnering with industry
NIHR partnering with industryNIHR partnering with industry
NIHR partnering with industry
 
The power of information: Achieving a national infection management system
The power of information: Achieving a national infection management systemThe power of information: Achieving a national infection management system
The power of information: Achieving a national infection management system
 
Automationinmicrobiology 100416000026-phpapp01
Automationinmicrobiology 100416000026-phpapp01Automationinmicrobiology 100416000026-phpapp01
Automationinmicrobiology 100416000026-phpapp01
 
Liquid based cytology ( l b c)
Liquid  based  cytology ( l b c)Liquid  based  cytology ( l b c)
Liquid based cytology ( l b c)
 
Earli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohnEarli19 presentation 13 aug19_charitonos_littlejohn
Earli19 presentation 13 aug19_charitonos_littlejohn
 
Earli19
Earli19Earli19
Earli19
 
ILRI’s key programs to address infectious diseases, areas requiring internati...
ILRI’s key programs to address infectious diseases, areas requiring internati...ILRI’s key programs to address infectious diseases, areas requiring internati...
ILRI’s key programs to address infectious diseases, areas requiring internati...
 
Covid19: Essentials for the Pharmacy Technician
Covid19: Essentials for the Pharmacy TechnicianCovid19: Essentials for the Pharmacy Technician
Covid19: Essentials for the Pharmacy Technician
 
BIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASESBIOMARKERS IN PERIODONTAL DISEASES
BIOMARKERS IN PERIODONTAL DISEASES
 
0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries0307 Mary Wang - Biobanks and registries
0307 Mary Wang - Biobanks and registries
 

More from Terra Vivos

VivosSouthAmerica
VivosSouthAmericaVivosSouthAmerica
VivosSouthAmericaTerra Vivos
 
vivossurvivalreport
vivossurvivalreportvivossurvivalreport
vivossurvivalreportTerra Vivos
 
Validation of the Q - Preven HIV 1 2 DBS Immunoenzyme Kit REPORT FIN 11012012
Validation of the Q - Preven HIV 1   2 DBS Immunoenzyme Kit REPORT FIN 11012012Validation of the Q - Preven HIV 1   2 DBS Immunoenzyme Kit REPORT FIN 11012012
Validation of the Q - Preven HIV 1 2 DBS Immunoenzyme Kit REPORT FIN 11012012Terra Vivos
 
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMO
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMOAPRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMO
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMOTerra Vivos
 
Reflecting on brazil’s success how durable what lessons for south africa
Reflecting on brazil’s success how durable what lessons for south africaReflecting on brazil’s success how durable what lessons for south africa
Reflecting on brazil’s success how durable what lessons for south africaTerra Vivos
 
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Terra Vivos
 
Consultancy activities andrã© s.efstathiou
Consultancy activities andrã© s.efstathiouConsultancy activities andrã© s.efstathiou
Consultancy activities andrã© s.efstathiouTerra Vivos
 
Q preven elisa.marketing..march 2012
Q preven elisa.marketing..march 2012Q preven elisa.marketing..march 2012
Q preven elisa.marketing..march 2012
Terra Vivos
 
Company formation ..directives
Company formation ..directivesCompany formation ..directives
Company formation ..directivesTerra Vivos
 
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Terra Vivos
 
Professional profile ase review
Professional profile ase reviewProfessional profile ase review
Professional profile ase review
Terra Vivos
 
Sales Projection --Bio Oxford
Sales Projection --Bio OxfordSales Projection --Bio Oxford
Sales Projection --Bio Oxford
Terra Vivos
 
Revista new lab artigo 6 inglês
Revista new lab artigo 6 inglêsRevista new lab artigo 6 inglês
Revista new lab artigo 6 inglês
Terra Vivos
 
Apresentação prime 092009_ing
Apresentação prime 092009_ingApresentação prime 092009_ing
Apresentação prime 092009_ing
Terra Vivos
 

More from Terra Vivos (14)

VivosSouthAmerica
VivosSouthAmericaVivosSouthAmerica
VivosSouthAmerica
 
vivossurvivalreport
vivossurvivalreportvivossurvivalreport
vivossurvivalreport
 
Validation of the Q - Preven HIV 1 2 DBS Immunoenzyme Kit REPORT FIN 11012012
Validation of the Q - Preven HIV 1   2 DBS Immunoenzyme Kit REPORT FIN 11012012Validation of the Q - Preven HIV 1   2 DBS Immunoenzyme Kit REPORT FIN 11012012
Validation of the Q - Preven HIV 1 2 DBS Immunoenzyme Kit REPORT FIN 11012012
 
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMO
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMOAPRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMO
APRESENTAÇÃO DOS PROJETOS DA AFRICA DO SUL..RESUMO
 
Reflecting on brazil’s success how durable what lessons for south africa
Reflecting on brazil’s success how durable what lessons for south africaReflecting on brazil’s success how durable what lessons for south africa
Reflecting on brazil’s success how durable what lessons for south africa
 
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
 
Consultancy activities andrã© s.efstathiou
Consultancy activities andrã© s.efstathiouConsultancy activities andrã© s.efstathiou
Consultancy activities andrã© s.efstathiou
 
Q preven elisa.marketing..march 2012
Q preven elisa.marketing..march 2012Q preven elisa.marketing..march 2012
Q preven elisa.marketing..march 2012
 
Company formation ..directives
Company formation ..directivesCompany formation ..directives
Company formation ..directives
 
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012Validation of the q   preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
Validation of the q preven hiv 1 + 2 dbs immunoenzyme kit report fin 11012012
 
Professional profile ase review
Professional profile ase reviewProfessional profile ase review
Professional profile ase review
 
Sales Projection --Bio Oxford
Sales Projection --Bio OxfordSales Projection --Bio Oxford
Sales Projection --Bio Oxford
 
Revista new lab artigo 6 inglês
Revista new lab artigo 6 inglêsRevista new lab artigo 6 inglês
Revista new lab artigo 6 inglês
 
Apresentação prime 092009_ing
Apresentação prime 092009_ingApresentação prime 092009_ing
Apresentação prime 092009_ing
 

Recently uploaded

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
SwastikAyurveda
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
SwastikAyurveda
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
Dr Maria Tamanna
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
SwisschemDerma
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
Dr. Rabia Inam Gandapore
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
AkankshaAshtankar
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
suvadeepdas911
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
Suraj Goswami
 

Recently uploaded (20)

Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Top 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in IndiaTop 10 Best Ayurvedic Kidney Stone Syrups in India
Top 10 Best Ayurvedic Kidney Stone Syrups in India
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
Colonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implicationsColonic and anorectal physiology with surgical implications
Colonic and anorectal physiology with surgical implications
 
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptxEffective-Soaps-for-Fungal-Skin-Infections.pptx
Effective-Soaps-for-Fungal-Skin-Infections.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Pictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdfPictures of Superficial & Deep Fascia.ppt.pdf
Pictures of Superficial & Deep Fascia.ppt.pdf
 
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAdv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Aortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 BernAortic Association CBL Pilot April 19 – 20 Bern
Aortic Association CBL Pilot April 19 – 20 Bern
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Gram Stain introduction, principle, Procedure
Gram Stain introduction, principle, ProcedureGram Stain introduction, principle, Procedure
Gram Stain introduction, principle, Procedure
 

Bio Oxford

  • 2. Bio-Oxford Bio-Oxford is a Brazilian company operating in the in vitro diagnostics market for over 10 years as an authorized distributor for Bio-Rad Laboratories, Inc., a multinational organization headquartered in the US, market and technology leader in various segments. Bio-Oxford has over 1,500 clients throughout Brazil and sells 5.8 million tests for in vitro diagnosis annually. Bio-Oxford also develops, imports, and commercializes products and equipment for in vitro diagnosis of infectious diseases for population screening and prenatal and neonatal screening.
  • 3. Bio-Oxford Bio-Oxford has expertise and works in all segments of the in vitro diagnostics market with a focus and leadership position in: POPULATION AND PRENATAL SCREEENING Equipment, chemical and biological reagents, sample collection kits, logistical and scientific training for infectious disease screening (AIDS, syphilis, hepatitis B and C, HTLV 1+ 2, toxoplasmosis, rubella, cytomegalovirus) for population and prenatal screening programs. a NEONATAL SCREENING Equipment, chemical and biological reagents, logistical and scientific training for beta-thalassemia, hemoglobinopathies, immunological and enzymatic disorders and infectious diseases screening in newborns. A
  • 4. Solutions Q-Preven ● Tests for General Population Screening ● Tests for Prenatal Screening ● Tests for Newborn Screening Blood samples collected on filter paper S&S903
  • 5. Business Philosophy ● Concept: Large population screening; ● Objective: 100% of the population; ● Method: Dried blood samples collected on filter paper (ELISA) Aim: Expedite access to patients Identify epidemiological profile
  • 6. Procedures for collecting blood on filter paper See sample enclosed
  • 7. Advantages Access Practicality Prevention Innovation Economy
  • 8. Advantages Access Practicality Prevention Innovation Economy • Epidemic moves to the interior •Need for laboratory infrastructure in remote areas • Filter paper carries the laboratory structure of urban centers to regions of difficult access.
  • 9. Advantages Access Practicality Prevention Innovation Economy • Easy method for sample collection -Whole blood •Optimum solid support for antibodies •Low volume and little invasive •(50ul/spot) •Transportation (non-infectious) • Simple storage at room temperature • Optimum stability
  • 10. Advantages Access Practicality Prevention Innovation Economy •Facilitates diagnosis and, as a result: • Immediate treatment and reduction of serious cases • Increased opportunities for prevention • Reduction of costs of service
  • 11. Advantages Access Practicality Prevention Innovation Economy • This method can be integrated into: •The rural indigenous population •The Family Health Program
  • 12. Advantages Access Practicality Prevention Innovation Economy • Cost reduction Transport Storage Equipment Material - Syringe needle -Collection tubes - Power (no centrifugation)
  • 13. The Advantages of Filter Paper vs. the Serum Method Logistics Serum Filter paper Extraction Syringe Lancet Preparation Centrifuge - Controlled temperature Conservation Room (Ice) Styrofoam Transport Envelope (Ice) Personnel Specialized Simple treatment Government studies show that, in Brazil, every AIDS patient costs US$4.500 per year, just for drugs. “Interview with Dr. Paulo Roberto Teixeira, Coordinator of the National STD/AIDS Department, Ministry of Health. Dr. Teixeira is a public health doctor and dermatologist and follows the AIDS issue from its inception.” Source: Boa Saúde UOL.
  • 14. Summary 1. Dried blood samples on filter paper are easy to collect, transport and store. 2. Results equivalent to those from the alternative testing method in serum. 3. An excellent solution for areas with no structure or with precarious laboratory structure. 4. Studies by Brazilian institutions show that, contrary to the syringe collection method, dried blood samples on filter paper maintain their properties under extreme temperature conditions such as 51oC, even when combined with high humidity.
  • 15. Summary In the Ministry’s assessment, of the 630,000 persons infected in Brazil, 255,000 who carry the virus have still not taken the test
  • 16. SECRETARIA DE VIGILÂNCIA EM SAÚDE • Normative instruction SVS/MS No. 151, October 14, 2009 • Official Gazette October 16, 2009 • LIST OF REASONS • ...“Brazil is going to update the standards for performing anti-HIV tests. The purpose is to include the most modern methods to increase the options for performing the exams at laboratories from the public and private systems in Brazil.” • The main change proposed by the STD/AIDS Department is meant to make testing to diagnosis HIV in the laboratory quicker. • The new document could also open the way for the first time for doing tests with dried blood, using the filter paper collection. The main advantage of the method is the ability to store blood samples for up to 12 weeks without refrigeration. This methodology, due to its easiness, doesn’t need specialized collection and transport, and, consequently, lowers the cost of exams. Another advantage is that the method allows for sending material by mail, taking the diagnostic method from the urban centers to more distant locations where there is no available laboratory capacity. Technically, the dried blood samples are not considered biologically infectious, which facilitates handling and transportation.
  • 17. The Importance of Prevention “HIV infection in the pediatric population is a growing problem, mainly in developing countries hit by the AIDS epidemic. The most frequent means for children to become HIV-positive is through their mothers, during pregnancy, labor or breastfeeding.
  • 18. The Importance of Prevention In the 21st century, the perinatal HIV epidemic remains out of control in many countries of the world. The Joint Program of the United Nations for HIV/AIDS (UNAIDS) estimates that 40 million people are living with HIV/AIDS, 5 million people are infected every year, of whom nearly 3 million are children; of these, 500,000 die as a result of infection and 700,000 will acquire new infections in that year, and many of them will be dead before reaching adolescence.
  • 19. The Importance of Prevention Whatever the disease, it is always better to identify it in the pre- symptomatic phase or in its early stages. This is the reason why programs that aim at prevention and early diagnosis of various pathologies are the main objective of current health initiatives. The main purpose of these educational and prevention initiatives is to provide all subsidies to publicize the information necessary to reduce the rates of infection and mortality. For example, treatment of syphilis, a disease that can cause blindness or even death in newborns, can be done with a single dose of benzathine penicillin in primary cases, or up to three doses (one per week), in cases of latent or secondary syphilis.
  • 20. The Importance of Prevention These initiatives can be applied to: • General Screening Programs: For men and women, for screening of diseases such as AIDS, syphilis, Chagas disease and hepatitis B and C. • Prenatal Screening Programs: To detect infectious disease in women before or during pregnancy. • Newborn Screening Programs: Screening (heel prick test) in newborns.
  • 21. The Importance of Prevention The importance of diagnostic tests to detect infectious diseases has been widely publicized by the Brazilian government, and various prevention programs have become mandatory in Brazil, such as the newborn screening program which is performed on all children born in the country. Programs with this scope, given their magnitude, can only be implemented using filter paper to collect samples. These programs, as well as the use of filter paper, were the subjects of reports, such as the two annexed to this presentation, which were broadcast on the Brazilian TV news program with the largest audience, with a statement by the Brazilian Minister of Health.
  • 22. AIDS in Brazil From 1980 to June 2009*, 544,846 AIDS cases were registered in Brazil. During this period, there were 217,091 deaths due to this disease. Every year, 33,000 to 35,000 new cases of AIDS are reported. In relation to HIV, the estimate is that there are 630,000 infected people in the Brazil. The epidemic grew inland. From 1997 to 2007, the incidence in cities with fewer than 50,000 inhabitants doubled, showing that the epidemic has moved inland. In 1997, the rate in cities with under 50,000 inhabitants was about eight times less than that reported for cities with over 500,000 people. In 2007, this ratio dropped to three times. Excerpted from: Boletim Epidemiológico Aids/DST 2009 Ministério da Saúde
  • 23. Syphilis Around 1 million new cases of syphilis are reported every year in Brazil, according to estimates from the Ministry of Health. After AIDS, the sexually transmitted disease of most concern to doctors is syphilis, mainly due to the transmission from mother to child. From 1998 to June of 2009, 55,124 cases of congenital syphilis (transmitted from mother to child) were reported in those younger than one year of age in Brazil. On average, 5,000 cases are reported every year. The Ministry of Health estimates, however, that there should be 12,000 reports annually. Beginning in 2005, cases of syphilis in pregnant women also began to be reported. From the beginning of notification up to 2008, 19,608 cases of pregnant women with syphilis were reported, with 6,955 just in the last year – the estimate is that around 48,000 pregnant women contract syphilis annually. From the perspective of public health, the main challenge in fighting syphilis is the vertical transmission. During pregnancy, the disease can cause miscarriage and death of the fetus. Its congenital manifestations include deformed bones, deafness, blindness and neurological problems, among others, for children. Excerpted from: Boletim Epidemiológico Aids/DST 2009 Ministério da Saúde
  • 24. The chances of vertical transmission of congenital syphilis can be eliminated and HIV infection can drop to 1%, if adequate prevention and treatment measures are adopted. Excerpted from: Boletim Epidemiológico Aids/DST 2009 Ministério da Saúde
  • 25. Population Screening Program for Infectious Diseases What Bio-Oxford provides: 1- Know-How: Bio-Oxford has been operating in the Brazilian market for over ten years, and has experience and extensive knowledge on the implementation, management and control of population screening programs destined to detecting infectious diseases and disorders in newborns.
  • 26. Population Screening Program for Infectious Diseases What Bio-Oxford provides: 2- Automated and/or semi-automated equipment: High technology equipment for processing of results, duly certified by the major public health agencies in the world, such as the FDA and the EC. All the equipment will be transferred under a loan scheme, with no additional cost to the program. 3- Specialized technical assistance for equipment maintenance and repair.
  • 27. Population Screening Program for Infectious Diseases What Bio-Oxford provides: 4- Collection kit: All the material needed to collect samples of blood (model enclosed). 5- Operational Training for Sample Collection: Training of the process multipliers in the use and care of the materials provided for the collection, storage, handling and transport of the samples.
  • 28. Population Screening Program for Infectious Diseases What Bio-Oxford provides: 6 – Chemical and Biological Reagents: Reagents needed to process samples, tested and approved by international public health agencies. 7 - Scientific Training: training laboratory personnel in methods, equipment and accessory operation, and interpretation of the results of processing the blood samples collected.
  • 29. Population Screening Program for Infectious Diseases What Bio-Oxford provides: 8- Web-based Management Program: Program for remote access to results based in the web, with access protected by individual password. (model enclosed). Ex: www.centrodegenomas.com.br Login: l (small “L”) 970 Password: bio970
  • 30. Population Screening Program for Infectious Diseases Bio-Oxford also has scientific knowledge, equipment and reagents to carry out several other programs and tests, such as: A – Prenatal tests to detect: AIDS, Syphilis, Hepatitis B and C, HTLV 1 +2, Toxoplasmosis, Rubella, Cytomegalovirus (CMV)
  • 31. Newborn screening B – Tests for Newborns to identify disorders: Tests Disease Total Thyroxin (T4) Congenital hypothyroidism Thyroid-stimulating hormone (TSH) Congenital hypothyroidism PKU enzyme test Phenylketonuria 17-α-Hydroxyprogesterone (17-OHP) Congenital Adrenal Hyperplasia Enzymatic galactose test Galactosemia Immunoreactive Trypsin (IRT) Cystic fibrosis Screening for hemoglobin disorders and Hemoglobin disorders and thalassemia thalassemia